Improve Medical Instruments300030.SZValuation Analysis

As of Oct 19, 2026, Improve Medical Instruments (300030.SZ) trades at a P/E of 66.00x, P/B of 3.06x, P/S of 4.63x, and a dividend yield of 0.00%.
Longitudinal percentile comparison: P/E sits at the 25th percentile over the trailing 10Y window (vs. 6th percentile over 3Y); P/B sits at the 56th percentile over the trailing 10Y window (vs. 39th percentile over 3Y); P/S sits at the 62nd percentile over the trailing 10Y window (vs. 54th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 69th percentile within its industry and the 69th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 0.00%; its historical percentile over the trailing long-term window is still accumulating data.
Notably, P/E and P/B aren't telling quite the same story, 30.5 points apart — worth checking the full percentile matrix on this page for the complete picture. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. Improve Medical Instruments operates in the Medicine sector. Data refreshes weekly and is for reference only, not investment advice.